Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Exchange Rate Effect (2018 - 2025)

Serina Therapeutics (SER) has disclosed Exchange Rate Effect for 4 consecutive years, with -$12000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect changed N/A to -$12000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$16000.0 through Dec 2025, down 900.0% year-over-year, with the annual reading at -$14000.0 for FY2025, N/A changed from the prior year.
  • Exchange Rate Effect hit -$12000.0 in Q4 2025 for Serina Therapeutics, down from -$2000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of -$12000.0 in Q4 2025 to a low of -$12000.0 in Q4 2025.